# Biofarm medicine sales suspension in Romania

> Live situation record from CLSTR: https://clstr.news/situations/biofarm-medicine-sales-suspension-in-romania
> Updated: 2026-08-09T09:43:43.000Z. Sources: 7. Developments: 2.

The manufacturer Biofarm suspended the sale of digestive and biliary medicines Colebil and Panzcebil across all distribution channels in Romania following a request from the National Agency for Medicines and Medical Devices (ANMDMR).

Initially, Biofarm characterized the suspension as a purely administrative measure intended to clarify product documentation, maintaining that the drugs met all safety and quality standards. However, subsequent reports indicated that the halt followed a reevaluation of the medications' benefit-risk ratio. These reports cited recent studies questioning the effectiveness of the active components and noted adverse reactions related to the gastrointestinal tract and liver in long-term users.

## Timeline

### 2026-08-09: Biofarm medicines Colebil and Panzcebil suspended in Romania

Romanian health authorities have suspended the sale of Colebil and Panzcebil medications for documentation review and benefit-risk reassessment.

2 sources. https://clstr.news/cluster/biofarm-medicines-colebil-and-panzcebil-suspended-in-romania

### 2026-08-04: Biofarm suspends sales of Colebil and Panzcebil in Romania

Biofarm temporarily halted sales of Colebil and Panzcebil in Romania after ANMDMR requested documentation clarification; safety is unchanged and no resumption date is set.

5 sources. https://clstr.news/cluster/biofarm-suspends-sales-of-colebil-and-panzcebil-in-romania

---
Cite as: Biofarm medicine sales suspension in Romania. CLSTR, https://clstr.news/situations/biofarm-medicine-sales-suspension-in-romania